HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Human Medicines
  • >CMDh
  • >Advice from CMDh
  • >Product-related advice
  • CMDh
    • About CMDh
    • Statistics
    • Agendas and Minutes
    • Press Releases
    • COVID-19
    • BREXIT
    • Nitrosamine impurities
    • Procedural Guidance
    • CMDh-Referrals
    • Product Information
    • Advice from CMDh
      • Procedural advice
      • Product-related advice
    • Templates
    • CMD Working Parties / Working Groups
    • Paediatric Regulation
    • Pharmacovigilance
    • Falsified Medicines
    • Questions & Answers
    • Contact Points
    • Recently Published history
  • MRI Product Index
  • Pharmacovigilance
  • Availability of Medicines
  • Publications and reports
  • National Contacts

 

Product-related advice

  • CMDh letter to MAHs of tenofovir disoproxil-containing medicinal products (February 2023, correction: June 2023)
  • Q&As on the implementation of the outcome of the Art. 31 referral on angiotensin-II-receptor antagonists (sartans) containing a tetrazole group (December 2021) [Tracked]
  • Harmonised warning for ferrous sulfate-containing medicinal products on dysphagia and related bronchostenosis due to risk of aspiration (May 2018) [Tracked]
  • Concomitant use of benzodiazepines/benzodiazepine like products and opioids (February 2018)

Deletion of interaction between broad spectrum antibiotics and combined oral contraceptives (COC)

  • Public Assessment Report (March 2015) corrected in March 2016 [Tracked]
  • List of ATC codes for which the change applies (January 2016)
  • CMDh letter for MAHs for medicinal products containing active ingredients in the form of Mesilates, Isetionates, Tosilates or Besilates (February 2008)

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/human-medicines/cmdh/advice-from-cmdh/product-related-advice.html